Irsogladine Maleate


Indications and Reactions:

Role Indications Reactions
Secondary
Depression 29.4%
Drug Use For Unknown Indication 15.7%
Gastric Ulcer 7.8%
Pyrexia 7.8%
Tooth Extraction 6.9%
Chronic Myeloid Leukaemia 3.9%
Hyperlipidaemia 3.9%
Insomnia 3.9%
Rheumatoid Arthritis 3.9%
Gastric Ulcer Helicobacter 2.9%
Rash 2.9%
Antibiotic Prophylaxis 2.0%
Gastritis 2.0%
Reflux Oesophagitis 2.0%
Hypertension 1.0%
Influenza 1.0%
Lumbago 1.0%
Product Used For Unknown Indication 1.0%
Promotion Of Peripheral Circulation 1.0%
Viral Rash 25.0%
Drug Eruption 12.5%
Erythema Multiforme 12.5%
Pyrexia 12.5%
Rash Generalised 12.5%
Cardio-respiratory Arrest 6.3%
Gastric Ulcer 6.3%
Rash 6.3%
Toxic Epidermal Necrolysis 6.3%
Concomitant
Rheumatoid Arthritis 25.2%
Drug Use For Unknown Indication 10.2%
Prophylaxis 8.1%
Chronic Myeloid Leukaemia 6.7%
Gastritis 6.6%
Product Used For Unknown Indication 5.3%
Behcet's Syndrome 5.0%
Hypertension 4.4%
Prophylaxis Against Gastrointestinal Ulcer 3.9%
Acute Lymphocytic Leukaemia 2.7%
Antibiotic Prophylaxis 2.6%
Insomnia 2.6%
Lymphoma 2.6%
Osteoporosis 2.5%
Diabetes Mellitus 2.2%
Aplastic Anaemia 2.1%
Infection Prophylaxis 2.1%
Herpes Zoster 1.9%
Gastritis Prophylaxis 1.6%
Hyperlipidaemia 1.6%
Electrocardiogram Qt Prolonged 8.5%
Rhabdomyolysis 8.5%
Renal Failure Acute 7.4%
Loss Of Consciousness 6.4%
Nasal Sinus Cancer 6.4%
Upper Gastrointestinal Haemorrhage 6.4%
Pyrexia 5.3%
White Blood Cell Count Increased 5.3%
Cerebral Haemorrhage 4.3%
Febrile Neutropenia 4.3%
Pneumonia 4.3%
Suffocation Feeling 4.3%
Tremor 4.3%
Vomiting 4.3%
White Blood Cell Count Decreased 4.3%
Alanine Aminotransferase Increased 3.2%
Feeling Abnormal 3.2%
Haemoptysis 3.2%
Lumbar Spinal Stenosis 3.2%
Pleural Effusion 3.2%

Drug Data